DCF — RUSSELL MEDICAL CENTER
Enterprise Value: $-169.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-169.5M
Enterprise Value
$-52.7M
PV of Cash Flows
$-116.8M
PV of Terminal Value
$-188.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $77.5M | $-11.1M | -14.0% | $-14.4M | $-13.1M |
| Year 2 | $79.8M | $-10.6M | -13.0% | $-14.0M | $-11.6M |
| Year 3 | $82.2M | $-10.1M | -12.0% | $-13.6M | $-10.2M |
| Year 4 | $84.7M | $-10.0M | -12.0% | $-13.6M | $-9.3M |
| Year 5 | $87.3M | $-10.1M | -12.0% | $-13.8M | $-8.5M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-169.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$75.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.14794482683153196
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5